Dr. Carolin C. Hack | Medicine and Dentistry | Best Scholar Award
Deputy clinical director at Erlangen University Hospital Womenβs Clinic, Germany
Priv.-Doz. Dr. med. Carolin Christine Hack is an accomplished medical professional and the Deputy Director of the Womenβs Clinic at the University Hospital Erlangen. With a specialization in gynecological oncology and integrative medicine, Dr. Hack combines her clinical expertise with a passion for patient-centered care. Her innovative approach to medicine, along with her extensive training and research, positions her as a leading figure in her field.
Profile
Education π
Dr. Hack completed her medical degree at Friedrich-Alexander University Erlangen-Nuremberg, where she also pursued her habilitation in βIntegrative Medicine in the Treatment of Gynecological Oncology Patients.β Her academic journey included a comprehensive curriculum that laid the groundwork for her clinical and research interests, ultimately leading to a robust foundation in both conventional and integrative medicine.
Experience πΌ
With over a decade of experience at the University Hospital Erlangen, Dr. Hack has advanced through various roles, from assistant physician to Deputy Director of the Womenβs Clinic. She has managed quality assurance initiatives and specialized in integrative medicine, focusing on the intersection of traditional and complementary therapies in patient care. Her leadership in the clinic has fostered a collaborative environment that emphasizes innovative treatment methodologies.
Research Interests π
Dr. Hackβs research primarily focuses on integrative medicine and complementary therapy methods, with a specific emphasis on mammographic density as a risk factor for breast cancer. Her work seeks to enhance patient outcomes through evidence-based practices that incorporate holistic approaches to treatment.
Awards π
Dr. Hackβs contributions to gynecological oncology have been recognized with multiple awards, including:
- 2015: Klaus-Dieter-Schulz-Versorgungsforschungspreis
- 2016: First Science Award from the German Society for Senology
- 2018: Award from the Foundation for Women and Child Health
- 2022: Research Award for Complementary Medicine from NATUM e.V.
Publications π
Dr. Hack has an extensive publication record, including:
- The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
- Authors: Ziegler, P., Hartkopf, A.D., Wallwiener, M., Schneeweiss, A., Goossens, C.
- Journal: BMC Cancer
- Year: 2024
- Volume: 24(1), Article 1284
- Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment
- Authors: Schmidt, E., Distel, L., Erber, R., Fietkau, R., Schnellhardt, S.
- Journal: Cancers
- Year: 2024
- Volume: 16(18), Article 3160
- Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
- Authors: Fasching, P.A., Hack, C.C., Nabieva, N., Fehm, T.N., HΓ€berle, L.
- Journal: European Journal of Cancer
- Year: 2024
- Volume: 209, Article 114239
- Correlation of RANK and RANKL with mammographic density in primary breast cancer patients
- Authors: Wunderle, M., Heindl, F., Behrens, A.S., Fasching, P.A., Emons, J.
- Journal: Archives of Gynecology and Obstetrics
- Year: 2024
- Volume: 310(2), pp. 1223β1233
- CDK4/6 Inhibition β Therapy Sequences and the Quest to Find the Best Biomarkers β An Overview of Current Programs
- Authors: Schneeweiss, A., Brucker, S.Y., Huebner, H., Fehm, T.N., Fasching, P.A.
- Journal: Geburtshilfe und Frauenheilkunde
- Year: 2024
- Volume: 84(5), pp. 443β458
- Initial experience with a next-generation low-field MRI scanner: Potential for breast imaging?
- Authors: Dietzel, M., Laun, F.B., HeiΓ, R., Uder, M., Ohlmeyer, S.
- Journal: European Journal of Radiology
- Year: 2024
- Volume: 173, Article 111352
- Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer
- Authors: Heger, L., Heidkamp, G.F., Amon, L., Beckmann, M.W., Dudziak, D.
- Journal: OncoImmunology
- Year: 2024
- Volume: 13(1), Article 2296713
- Predicting mammographic density with linear ultrasound transducers
- Authors: Behrens, A., Fasching, P.A., Schwenke, E., Beckmann, M.W., Emons, J.
- Journal: European Journal of Medical Research
- Year: 2023
- Volume: 28(1), Article 384
- Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows
- Authors: Lehle, S., Emons, J., Hack, C.C., Ruebner, M., Huebner, H.
- Journal: Scientific Reports
- Year: 2023
- Volume: 13(1), Article 373
- Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care β The PreFace Study
- Authors: Hack, C.C., Maass, N., Aktas, B., Hein, A., Fasching, P.A.
- Journal: Geburtshilfe und Frauenheilkunde
- Year: 2023
- Volume: 84(2), pp. 185β195
Conclusion β¨
Priv.-Doz. Dr. med. Carolin Christine Hack is an exemplary candidate for the Best Researcher Award. Her innovative contributions to integrative medicine and gynecological oncology, coupled with her extensive publication record and commitment to patient care, position her as a leader in her field. By addressing areas for improvement, such as interdisciplinary collaboration and public engagement, Dr. Hack can further enhance her impact in research and continue to advance the frontiers of medical knowledge.